Investors are getting excited over a radical new farming technology that is making waves in the media, and in the market.
BVT is a rapidly growing agritech company behind the headline-making technology. Instead of using pesticides, bee vectoring relies on bees to transport beneficial microbes directly to flowers, and the Company’s biological CR-7 recently won EPA approval in the US.
Mr. Collinson has more than 35 years of experience in international manufacturing, marketing and sales management. From 2012 to 2016 he served as President and CEO of BVT and was responsible for encouraging the Company’s growth from an R&D initiative to a commercial opportunity.
He joined Omri on StockTalk to discuss BVT’s rapidly rising star, the giant market opportunity the Company is facing, and where they're headed next.